Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China

Related articles

07 Feb 2017 : Clinical Research

Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland

Joanna Smoleń-Dzirba, Magdalena Rosińska, [...] Piotr Kruszyński, Jolanta Bratosiewicz-Wąsik, Robert Wojtyczka, Janusz Janiec, Bartosz Szetela, Marek Beniowski, Monika Bociąga-Jasik, Elżbieta Jabłonowska, Tomasz J. Wąsik, and The CASCADE Collaboration in EuroCoord - Show fewer authors

DOI: 10.12659/MSM.898656

10 Jan 2014 : Original article

Role of KIR genes and genotypes in susceptibility to or protection against hepatitis B virus infection in a Turkish cohort

Filiz Kibar, Ozlem Goruroglu Ozturk, [...] Aslıhan Ulu, Eren Erken, Seza Inal, Suzan Dinkci, Behice Kurtaran, Yesim Tasova, Hasan Salih Zeki Aksu, Akgun Yaman - Show fewer authors

DOI: 10.12659/MSM.889893

26 Feb 2014 : Research paper

An initial assessment of correlations between host- and virus-related factors affecting analogues antiviral therapy in HBV chronically infected patients

Piotr Stalke, Magda Rybicka, [...] Anna Wroblewska, Marcin Dreczewski, Ewa Stracewska, Tomasz Smiatacz, Krzysztof Piotr Bielawski - Show fewer authors

DOI: 10.12659/MSM.889788

09 Sep 2013 : Original article

Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: A pilot study

Qing-Wei Du, Ji-Guang Ding, [...] Qing-Feng Sun, Liang Hong, Fu-Jing Cai, Qing-Qing Zhou, Yang-He Wu, Rong-Quan Fu - Show fewer authors

DOI: 10.12659/MSM.889443

02 Nov 2017 : Clinical Research

Comparing Efficacy of Lamivudine, Adefovir Dipivoxil, Telbivudine, and Entecavir in Treating Nucleoside Analogues Naïve for HBeAg-Negative Hepatitis B with Medium Hepatitis B Virus (HBV) DNA Levels

Hong Shi, Zongping Han, [...] Jian Liu, Jinfang Xue, Shuya Zhang, Zhe Zhu, Jinyu Xia, Mingxing Huang - Show fewer authors

DOI: 10.12659/MSM.903382

12 Dec 2017 : Original article

A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B

Ho Joong Choi, Dong Goo Kim, [...] Soon Il Kim, Hee Jung Wang, Jae Won Joh, Kyung Suk Suh, Seong Hoon Kim - Show fewer authors

DOI: 10.12659/AOT.905898

01 Apr 2010

Inactive Hepatitis B carriage, HBV DNA level and biopsy

Aziz Ogutlu, Oguz Karabay

29 Jan 2009

Peginterferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomised study

Vasileios P. Papadopoulos, Dimitrios N. Chrysagis, [...] Andreas N. Protopapas, Ioannis G. Goulis, Georgios T. Dimitriadis, Konstantinos P. Mimidis - Show fewer authors

29 Apr 2008

Determination of lamivudine-resistant variants of hepatitis B virus by denaturing gradient gel electrophoresis: a novel approach to monitoring drug resistance

Krzysztof Piotr Bielawski, Waleed Abu Al-Soud, [...] Piotr Stalke, Urszula Charmuszko, Torkel Wadstrom - Show fewer authors

03 Sep 2007

Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin

Urszula Ołdakowska-Jedynak, Leszek Paczek, [...] Bartosz Foroncewicz, Krzysztof Mucha, Paweł Nyckowski, Krzysztof Zieniewicz, Bogna Ziarkiewicz-Wróblewska, Jacek Ziółkowski, Tomasz Pilecki, Waldemar Patkowski, Barbara Górnicka, Agata Paczkowska, Marek Krawczyk - Show fewer authors